MAIA Biotechnology, Inc. (MAIA)
NYSEAMERICAN: MAIA · Real-Time Price · USD
1.350
-0.040 (-2.88%)
At close: Aug 24, 2026, 4:00 PM EDT
1.400
+0.050 (3.70%)
Pre-market: Aug 25, 2026, 4:07 AM EDT
MAIA Biotechnology Market Cap
MAIA Biotechnology has a market cap or net worth of $82.11 million as of August 24, 2026. Its market cap has increased by 57.52% in one year.
Market Cap
82.11M
Enterprise Value
54.52M
1-Year Change
57.52%
Ranking
Category
Stock Price
$1.35
ChartMarket Cap Chart
Since the IPO on July 28, 2022, MAIA Biotechnology's market cap has increased from $51.10M to $82.11M, an increase of 60.69%. That is a compound annual growth rate of 12.34%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 24, 2026 | 82.11M | 40.26% |
| Dec 31, 2025 | 58.55M | 13.04% |
| Dec 31, 2024 | 51.79M | 161.26% |
| Dec 29, 2023 | 19.82M | -48.40% |
| Dec 30, 2022 | 38.42M | -24.81% |
| Jul 28, 2022 | 51.10M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Gain Therapeutics | 87.29M |
| Dogwood Therapeutics | 87.02M |
| Gossamer Bio | 85.55M |
| Verrica Pharmaceuticals | 83.66M |
| Cingulate | 82.60M |
| Eloxx Pharmaceuticals | 80.69M |
| Telomir Pharmaceuticals | 80.47M |
| OKYO Pharma | 78.72M |